BIOSYNEX AMPLIQUICK® SARS-CoV-2 is an in vitro molecular diagnostic test for the qualitative detection of SARS-CoV-2 (the virus responsible for Covid-19) using RNA extract obtained from nasopharyngeal or salivary samples. This test detects two molecular targets of SARS-CoV-2 located on the RdRp and E genes.
AMPLIQUICK® SARS-CoV-2
- Sample Collection: BIOSYNEX AMPLIQUICK® Sample Collection / Kit of 100 swabs + 100 tubes of transport medium
- RNA Extraction: BIOSYNEX AMPLIQUICK® Lysis – Rapid lysis kit in 15 minutes – 96 well microplates pre-filled with lysis buffer – Compatible with most commercial RNA extraction kits
- Pathogen and target genes: SARS-Cov-2 / RdRp and E
- Internal control: RNaseP
- Reaction media: 96-well microplates pre-filled with the Master Mix – + and – control tubes provided
- Number of tests: 480
- Detection limits: – Extracted and purified RNA : SARS-CoV-2: 1 copy / µL – BIOSYNEX AMPLIQUICK® Lysis: SARS-CoV-2: 1 copy / µL
- Compatible thermal cyclers: For 0.1 or 0.2 mL low-profile block with FAM, HEX and Cy5 detection channels (refer to the instructions)
-
Product description
-
Associated products
Our product range
These products might interest you
Documentation
Download all technical documents, certificates, communication media reserved for healthcare professionals.